News

Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program

Defense Threat Reduction Agency (DTRA) contract is expected to advance development of Tonix’s broad-spectrum oral antiviral program TNX-4200 for medical…

1 year ago

Korro Joins the Russell 2000®, Russell 3000®, and Russell Microcap® Indexes

CAMBRIDGE, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing…

1 year ago

Halo Dental Technologies Wins Prestigious Red Dot Award for Design Concept 2024 with Innovative Halo Digital Mirror

Revolutionizing Patient Care and Clinical Workflows with Cutting-Edge Dental Technology Halo Digital Mirror Image The Halo Digital Mirror boosts patient…

1 year ago

Merus Appoints Fabian Zohren M.D., Ph.D., as Chief Medical Officer

UTRECHT, The Netherlands and CAMBRIDGE, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we,…

1 year ago

Biora Therapeutics Announces Positive Clinical Trial Results for BT-600

Drug-device combination leverages Biora’s NaviCap™ platform to deliver tofacitinib directly to colonic tissue as a potential treatment for ulcerative colitis…

1 year ago

Syncromune Granted FDA Fast-Track Designation for SYNC-T SV-102 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

FORT LAUDERDALE, Fla., July 01, 2024 (GLOBE NEWSWIRE) -- Syncromune® Inc., a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for…

1 year ago

Vera Therapeutics Announces Appointment of Industry Veteran David L. Johnson as Chief Operating Officer

BRISBANE, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on…

1 year ago

CBIH advances Cancer Care with Novel Cannabis Patents for Breast and Pancreatic Cancers

HOUSTON, July 01, 2024 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is excited to announce the submission of…

1 year ago

Achieve Life Sciences Announces Addition to the U.S. Russell 3000® and Russell Microcap® Indexes

SEATTLE and VANCOUVER, British Columbia, July 01, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical…

1 year ago